Moshe Citronowicz - 15 Mar 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Senior Vice President
Issuer ticker: APYX
Reported as of: 15 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Mar 2026, 18:27:04 UTC
Prior SEC filing: 19 May 2025
Next SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Moshe Citronowicz

Key filing fact

Moshe Citronowicz filed Form 4 for Apyx Medical Corp (APYX) on 17 Mar 2026.

Key facts

This page summarizes Moshe Citronowicz's Form 4 filing for Apyx Medical Corp (APYX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Mar 2026, 18:27.

Change

Previous filing in this sequence was filed on 19 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001280851 Primary reporting owner

CITRONOWICZ MOSHE

Relationship: Senior Vice President
Address: C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
Signature: /s/ Moshe Citronowicz
Signature date: 17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APYX transaction

Common Stock

Options Exercise

Transaction value
Shares: +37,000
Change %: +8.1%
Price: $1.80^*
Shares after: 493,504
Date: 15 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
Shares: -37,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,000
Exercise price: $1.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 15, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 37,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan.